16 Middle East respiratory syndrome coronavirus (MERS-CoV) continues to cause zoonotic infections 17 and serious disease, primarily in the Arabian Peninsula, due to repeated spill-over from dromedary 18 camels and subsequent nosocomial transmission. Approved MERS vaccines for use in animals or 19 humans are not currently available. MERS-CoV replication requires the virus-encoded papain-like 20 protease (PL pro ) to cleave multiple sites in the viral replicase polyproteins, thereby releasing 21 functional non-structural proteins. Additionally, PL pro is a deubiquitinating enzyme (DUB) that can 22 3 39
remove ubiquitin(-like) moieties from substrates, presumably to counteract host antiviral responses.
23
In previous work, we determined the crystal structure of MERS-CoV PL pro in complex with ubiquitin, 24 facilitating the design of PL pro mutations that impair DUB activity without affecting viral polyprotein 25 cleavage. Here, we introduced these DUB-inactivating mutations into the viral genome and 26 examined their impact on MERS-CoV infection both in cell culture and in a lethal mouse model. earlier stage of infection than in wt virus-infected mice. This group also showed a clearly increased 52 survival, indicating that the DUB activity is an important MERS-CoV virulence factor. This proof-of-53 concept study establishes that the engineering of DUB-negative coronaviruses, which elicit a more 54 effective immune response in the host, is a viable strategy for vaccine development.
Introduction 81 nuclear translocation of the transcription factors interferon regulatory factor (IRF) 3, IRF7 and NF-κB, 82 which drives expression of antiviral molecules such as interferons (IFNs) and other pro-inflammatory 83 cytokines. Type I IFNs (IFN-α/β) and type III IFNs (IFN-λ) induce expression of interferon-stimulated 84 genes (ISGs) with the distinction that, due to receptor restrictions, IFN-λ can only induce ISGs in 85 epithelial cells, whereas ISGs induced by type I IFNs can be expressed by virtually any cell type (14, 86 15) . ISGs are antiviral effector proteins that limit virus replication and spread. Moreover, some ISGs 87 can enhance pathogen recognition and thereby innate immune signalling (16) . NF-κB-mediated 88 production of cytokines like TNF-α, IL-6, and IL-8, are important for the inflammatory response as 89 well as for attracting and activating immune cells (17) . Type I IFNs also play a major role in 90 stimulating expression and production of other immune mediators like IFN-γ and cytokines by 91 diverse innate immune cells. Additionally, antigen presentation by dendritic cells is enhanced and 92 also the survival and activity of B and T cells is modulated by type I IFNs, which underlines the 93 importance of type I IFNs in shaping adaptive immune responses (18, 19) . The fine-tuning of innate 94 immune responses is crucial and therefore the activities of signalling molecules in these pathways 95 are tightly regulated by post-translational modifications such as phosphorylation and ubiquitination 96 (20) . Ubiquitination is the covalent conjugation of ubiquitin (Ub), an evolutionally conserved protein, 97 via attachment of its C-terminal Gly76 residue to the N-terminal residue or any Lys residue of a 98 protein substrate (21) . Conjugation of Ub can also occur to previously conjugated Ub moieties on the 99 N-terminus or at any of the seven Lys residues in Ub itself, leading to the formation of polyUb chains 100 with different topologies and functions (22, 23) . Ubiquitination is performed by a cascade of three 
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The following targets were amplified: IFN-β (5'-GTCACTGTGCCTGGACCATA-3' and 5'- 
274
Homogenized samples were centrifuged at 9,500 x g for 5 min and supernatants were collected.
275
Thereafter, rMERS-CoV titers were determined by plaque assay on HuH7 cells as described before.
276
Statistical significance (p < 0.05) between wt and V1691R rMERS-CoV titers was determined using an 277 unpaired Student's t-test.
278

RNA isolation from lungs of rMERS-CoV-infected mice and RT-qPCR 280
To preserve the integrity of RNA, lungs were soaked in RNAlater (Thermo Fischer Scientific) directly 281 after harvesting, and stored at -80°C. For RNA extraction, lungs were transferred to a gentleMACS M 282 Tube containing 2 ml of RA1 buffer (Machery-Nagel) supplemented with 1% β-mercaptoethanol.
283
Tissue was dissociated in the gentleMACS dissociator using program RNA_02 (Miltenyi Biotec).
284
Subsequently, samples were centrifuged at 9,500 x g for 5 min and supernatants were aliquoted.
285
RNA was then isolated following the standard protocol of the NucleoSpin RNA II kit (Machery-Nagel).
286
RT-qPCRs and their analysis were performed as described above but with the following deviation. To 287 measure mRNA levels of CCL5, IL-6, and IFIT2, a triplex qPCR with TaqMan probes was performed 288 with HotStarTaq Master mix (Qiagen) whereas all other targets were amplified using gene-specific 289 primer sets and iTaq SYBR Green Supermix (BioRad). All primers and probe sequences can be 290 requested.
291
The obtained cDNA was also used to verify that the V1691R substitution in MERS-CoV PL pro 292 was retained after several rounds of virus replication in mice. PCR and sequencing to determine the 293 PL pro -coding sequence was executed as described above. 
338
To launch wt and mutant rMERS-CoV, BHK-21 cells were transfected with in vitro transcribed 339 MERS-CoV RNA. Progeny virus was harvested and virus stocks were then grown in HuH7 cells. Virus-340 induced CPE was observed for the wt control as well as all DUB-negative mutants listed in the 341 previous paragraph, indicating that these viruses were viable and cytopathogenic in cell culture.
342
Virus titers were determined by plaque assay on HuH7 and MRC5 cells and additionally plaque 343 phenotypes were examined. The plaque size of rMERS-CoV V1691R was slightly smaller compared to 344 wt rMERS-CoV on both cell lines (Fig 1) . Plaques of mutants T1653R and V1674S were comparable in 345 size to those of the wt control. However, when combined with the V1691R substitution in double or 346 triple mutants, plaque sizes were more variable and on average slightly decreased (Fig 1) . (Fig 2A and B) . Also, the other mutants yielded titers comparable to wt virus 24 h p.i. when 363 MRC5 cells were infected with MOI 1 (Fig 2C) . Notably, rMERS-CoV peak titers were approximately 364 1-log higher in MRC5 cells compared to HuH7 cells. For multi-cycle infection experiments, cells were 365 infected with an MOI of 0.01 and virus-containing supernatants were harvested 24 and 48 h p.i. At 366 both these time points, there was no significant titer difference between wt virus and mutant 367 V1691R (Fig 2D-G) . Essentially similar results were obtained for all other DUB-negative mutants 368 tested (Fig 2D-G) , suggesting that overall replication in human cells is not affected by substitutions in 369 the Ub-binding site of MERS-CoV PL pro .
370
Despite the lack of clear replication differences in cell culture, we anticipated that viruses wt rMERS-CoV (Fig 3A-C) . The double mutant showed a more pronounced increase while the single 385 T1653R mutation did not affect the mRNA levels of the qPCR targets at all (Fig 3A-C) . Also, cells 386 infected with viruses carrying the V1674S substitution induced a very low response comparable to 387 that against wt virus (Fig 3A-C) . Wild-type and mutant viral genomic RNA levels were similar in 388 infected cells (Fig 3D) . In multicycle infections of MRC5 cells, V1691R rMERS-CoV induced higher 389 levels of IFN-β and ISGs mRNA than wt virus (IFN-β ~3-fold, IFIT2 ~4-fold, and viperin ~8-fold; Fig 3E- 390 G). This was even more pronounced with the double mutant, while addition of the V1674S 391 substitution unexpectedly reduced IFN-β and ISG responses relative to the double mutant (Fig 3E-G) .
392
The additive effect of T1653R implies that this substitution, when combined with V1691R, is further 393 reducing Ub-binding. PL pro mutants T1653R and V1674S generated responses comparable to those 394 against wt virus, and virus genome levels were similar (Fig 3E-H) . Interestingly, MERS-CoV genome 395 levels were lower in cells infected with V1691R, with the double, and with the triple mutant, 396 compared to wt virus in these multicycle infections (Fig 3H) , indicating that these mutations 
412
We aimed to investigate V1691R rMERS-CoV infection of these transgenic mice with respect 413 to its lethality and the innate immune responses in the lung. To this end, mice were infected intranasally with 1x10 5 PFU of either wt or DUB-negative rMERS-CoV, whereas a third group of mice 415 was mock-infected. Each group contained a total of 16 mice of which 12 animals per group were 416 euthanized at early time points. The remaining four animals from each of these three groups were 417 monitored for a period of 14 days to assess their survival and measure their body weight on a daily 418 basis. All four mice infected with wt rMERS-CoV died or had to be euthanized after reaching a 419 humane endpoint by day 7 or 8 p.i. (Fig 4A) . In contrast, only one of the four mice infected with 420 DUB-negative rMERS-CoV died at day 8 p.i., while the other three mice survived for the full 14-day 421 period (Fig 4A) . Even with the small number of animals used for this experiment, this difference in 422 survival between mice infected with wt or DUB-negative rMERS-CoV is statistically significant (log-423 rank test p value = 0.028). Both wt and DUB-negative rMERS-CoV-infected mice lost weight over the 424 course of infection (Fig 4B) , but in all three surviving mice infected with DUB-negative rMERS-CoV 425 this weight loss was reversed from day 10 p.i. forward (Fig 4C) . The results clearly suggested that the 426 virulence of the DUB-negative virus was reduced compared to wt virus. 427 428
DUB-negative rMERS-CoV is cleared faster from mice lungs than wt virus 429
To measure rMERS-CoV replication and the innate immune responses the viruses elicited in lungs of 430 infected mice, we euthanized four animals from each group at days 1, 2, and 4 p.i. Lungs were 431 removed and part of the material was homogenized and used for virus titration. For wt rMERS-CoV, 432 progeny titers were approximately 1x10 6 PFU per g of lung tissue during the first four days after 433 infection (Fig 5) . The DUB-negative virus reached similar virus titers as the wt control during the first 434 two days p.i., indicating that this virus also replicates well in mice. Unexpectedly, however, it proved 435 impossible to recover virus from the lungs of three of the mice infected with DUB-negative rMERS-
436
CoV (twice in the day 1 p.i. group, and once in the day 2 p.i. group; Fig 5) . Consequently, it remains 437 unclear whether these three animals had been successfully inoculated. All DUB-negative rMERS-CoV-438 infected mice that were euthanized at day 4 p.i. were virus-positive, and their lung titers were 439 significantly lower than in wt virus-infected mice at that time point (Fig 5) , suggesting that the DUB-negative virus is cleared faster from the lungs than wt rMERS-CoV. Virus titers were also determined 441 in mice that died from the infection at day 7-8 p.i. and in survivors of the infection at day 14. By day 442 7-8 p.i., the rMERS-CoV wt titers were around 1x10 4 PFU per g of lung tissue, signifying that virus 443 titers decreased over time (Fig 5) . The virus titer of the single mouse that died of the DUB-negative 444 virus infection was 2x10 3 PFU per g of lung tissue (Fig 5) . Virus could not be recovered from the lungs 445 of any of the mice that had survived the infection with DUB-negative rMERS-CoV after 14 days (Fig   446  5) .
447
In order to verify whether the DUB-inactivating substitution in the MERS-CoV mutant was 448 stably maintained during the animal experiment, sequencing of the PL pro -coding region of the 449 genome was performed. To this end, lung tissue was homogenized, RNA was isolated, and the PL pro -450 coding sequence was amplified by RT-PCR and sequenced. In wt virus-infected mice, the consensus 451 sequence of the PCR product was found to be identical to the sequence of the BAC-based cDNA 452 clone from which the rMERS-CoV had been launched (data not shown). RT-PCR and sequencing were 453 successful using RNA isolated from all mice infected with DUB-negative rMERS-CoV from which also 454 DUB-negative rMERS-CoV was recovered (Fig 5) , and revealed the presence of the V1691R 455 substitution in PL pro without additional substitutions in PL pro (data not shown). No virus-specific RT-456 PCR product could be obtained from the lungs of mice that were found negative for infectious virus 457 at day 1 or 14 p.i. (data not shown; Fig 5) . For one mouse inoculated with DUB-negative rMERS-CoV, 458 although virus could not be isolated at 2 days p.i. (Fig 5) , a virus-specific RT-PCR product could be 459 obtained using another piece of its lung, after which the presence of the PL pro mutation could be 460 confirmed by sequencing. Possibly, in this particular mouse, the virus was distributed unequally in 461 the lungs during intranasal inoculation, explaining why only some parts were virus-positive at 2 days 462 p.i. Similar issues may explain the lack of virus isolation for the two mice that were negative for the 463 mutant virus at 1 day p.i., as for the described experiments not the entire lungs were used, and as 464 there was no obvious technical reason to suggest inoculation failure. Overall, our data established that the DUB-negative virus, which stably maintained the V1691R substitution, is cleared faster from 466 the lungs of infected mice than wt virus. (ISG15 and IFIT2) , the cytokine TNFα that is controlled by NF-κB activation, the pro-478 inflammatory cytokine IL-6, and the chemokine CCL5 (Fig 6) (76) .
479
After the first day of infection, the mRNA levels for all targets were similarly low in wt and 480 DUB-negative rMERS-CoV-infected mice (Fig 6) . At 2 days p.i., transcript levels in wt rMERS-CoV-481 infected mice were comparable to those in mock-infected mice while a clear increase was measured 482 in DUB-negative rMERS-CoV-infected mice (Fig 6) . For ease of visualization, the mean fold increase 483 for each target is presented in Fig 6, while the fold increase for each individual mouse is displayed in 484 S1 Fig to be able to show the variation in the responses between mice in the same group. Notably, 485 the IFN-β and IFN-λ values for the wt MERS-CoV-infected mice showed less variation than those of 486 the mock-infected animals, suggesting that the wt virus efficiently suppressed the expression of 487 these cytokines at day 2 p.i. (S1A and B Fig, compare fold increase of mock and wt-infected mice at 488 day 2 p.i.). The mean level of IFN transcripts in DUB-negative rMERS-CoV-infected mice was clearly, 489 although not statistically significantly, higher than in the mock and wt virus-infected mice (Fig 6A   490  and B) . ISG15 and IFIT2 mRNA levels were found to be slightly elevated in wt rMERS-CoV-infected mice relative to mock-infected mice, while an even more pronounced increase was seen in DUB-492 negative rMERS-CoV-infected mice (Fig 6C and D) . The upregulation of IFN-β mRNA in individual 493 DUB-negative MERS-CoV-infected mice corresponded to the increased levels of ISG mRNAs in the 494 same mice at 2 days p.i. (S2 Fig) This illustrates that the ISG responses measured were likely induced 495 by upregulation of type I IFNs in these animals. Due to the limited group size and considerable 496 variation in the responses between the four mice that received DUB-negative rMERS-CoV (S1 Fig,   497 see fold increase of DUB-negative virus-infected mice at day 2 p.i.), the difference in mRNA levels 498 between wt and DUB-negative rMERS-CoV-infected mice at 2 days p.i. was not statistically 499 significant. However, the trend of an accelerated increase of mRNA levels was clearly there for all 500 innate immune targets upon infection with DUB-negative rMERS-CoV. This strongly suggests that, 501 compared to the wt control virus, the DUB-negative virus is less able to suppress innate immune 502 responses resulting in an earlier reaction.
503
By day 4 p.i., a very different innate immune response in the mice was seen compared to the 504 response at 2 days p.i. (Fig 6) . In the DUB-negative virus group, the increase of innate immune 505 transcripts was slightly lower relative to 2 days p.i. (Fig 6) , and the variation in mRNA levels between 506 the four mice was smaller in this group at 4 days than at 2 days p.i. (S1 Fig, compare e. g. the IFN-β 507 fold increase of each individual V1691R-infected mouse at day 2 p.i. with day 4 p.i.), suggesting 508 down-regulation of the response by day 4 p.i. in this group of mice. Wild-type virus-infected mice 509 showed, however, a very strong increase in transcript levels for all tested targets between 2 and 4 510 days p.i. Especially the mRNA levels of IFN-β, IFN-λ, and IL-6 were remarkably upregulated (Fig 6A, B,   511 and F). Together, this demonstrates that between 2 and 4 days p.i. the mRNA levels of innate 512 immune factors, cytokines, and chemokines were already down-regulated in the DUB-negative virus-513 infected mice, in contrast to the strong upregulation observed for rMERS-CoV wt-infected mice.
514
We expected that the early immune responses would be further down-regulated over time 515 in the mice infected with the DUB-negative mutant. To confirm this, mRNA levels were determined 516 in lungs of the three surviving mice infected with V1691R rMERS-CoV and mock-infected mice at 14 517 days p.i. The number of transcripts of innate immune factors and cytokines was similar between 518 these two groups, indicating that all mRNAs in surviving animals were back to an almost basal level Fig 3) . However, this 555 upregulation of the type I IFN response did not reduce the progeny titers of DUB-negative rMERS-
556
CoV in MRC5 cells (Fig 2) . We did observe that the plaque size of rMERS-CoV containing the V1691R 557 substitution was slightly smaller when compared to wt virus (Fig 1) , suggesting that the mutant virus 558 was somehow affected after all. Also, in multi-cycle infections, MERS-CoV genome levels were 559 reduced upon infection with DUB-negative MERS-CoVs carrying the V1691R substitution (Fig 3H) (Fig 5) . Although this is lower 589 than the previously reported peak titer at 2 days p.i. of 6x10 7 PFU per g of lung tissue (73) infection was lethal also in our hands, and all mice died at 7-8 days after infection (Fig 4A) . Likely, 597 the mice that succumbed to the infection also had MERS-CoV infection of the brain, however, the 598 experimental circumstances did not allow us to take samples to support this assumption. Strikingly, 599 infection with the DUB-negative virus resulted in a significantly increased survival compared to the 600 animals infected with the wt virus (Fig 4A) . The DUB-negative virus reached the same titers in the 601 lungs as the wt virus by 2 days p.i., but these had dropped significantly by 4 days p.i. while they 602 stayed high in the wt virus-infected mice (Fig 5) . In future research, it will be interesting to 603 determine whether histopathology is reduced in mice infected with DUB-negative rMERS-CoV to 604 confirm that earlier virus clearance and reduced tissue damage correlates with increased survival, 605 relative to in wt virus-infected mice.
606
Messenger RNA levels for IFNs (IFN-β and IFN-λ), ISGs (ISG15 and IFIT2), and pro-607 inflammatory cytokines (IL-6 and TNFα) started to rise in lungs of DUB-negative rMERS-CoV-infected 608 mice at 2 days p.i. (Fig 6) . Although there was no statistically significant difference compared to wt 609 virus-infected mice, the trend of faster upregulation of these mRNAs was quite clear. Moreover, the 610 fact that the levels for all these transcripts increased simultaneously strengthens the conclusion that 611 the DUB-negative rMERS-CoV induced an accelerated innate immune response compared to the wt 612 virus, again confirming the role of the PL pro DUB activity in suppression of innate immune responses, 613 now also in the context of a mouse model. The transcript levels of IFNs and cytokines slightly 614 decreased in DUB-negative rMERS-CoV-infected mice at 4 days p.i., but in wt rMERS-CoV-infected 615 mice the mRNA levels were extremely upregulated (Fig 6) . We therefore hypothesize that the 616 difference in survival rate is likely due to an accelerated, and after induction properly down-617 regulated, innate immune response in DUB-negative virus-infected mice, which is likely more 618 effectively clearing the virus and preventing tissue damage, protecting these mice from lethality 619 (Figs 4-6) . In contrast, the response in wt virus-infected mice is first suppressed and then at later 620 time points it is extremely upregulated (Fig 6) . be related to the course of infection, as the weight loss of this third mouse was the smallest of the 638 three mice that survived the infection (Fig 4C, mouse 1 vaccines are currently being designed for use in humans as well as dromedary camels, the latter 645 aiming to reduce virus circulation and transmission to humans (84-86).
646
In summary, our results demonstrate, for the first time, that the presence of PL pro 's DUB 647 activity causes a delay in the innate immune response, which has a major impact on pathogenesis in 648 the mouse model used. Pathogenesis and lethality can thus be reduced by removal of the DUB 649 activity, resulting in earlier, better-regulated and therefore likely more effective innate immune 650 response that helps to clear the virus and decreases pathogenicity, despite the initial viral replication 651 being similar to that seen in wt virus infections. Our study has thus also provided the proof-of- CoV field, the "attenuation-by-design" approach to eliminate one or more innate immune evasive 658 functions may offer a general and effective strategy for MLV development. 
Figure legends
709
The mean per group is presented and the dashed line represents the average that was set to 1 for 710 the mock-infected mice. Statistical significance between wt and DUB-negative MERS-CoV-infected 711 mice is shown (* p < 0.05).
